Literature DB >> 2839224

Sexually transmitted diseases including genital papillomavirus infection in male sexual partners of women treated for cervical intraepithelial neoplasia III by conization.

P Bistoletti1, P Lidbrink.   

Abstract

History and clinical prevalence of sexually transmitted diseases (STD), including genital human papillomavirus (HPV) infection, were studied in 60 sexual partners of 60 women previously treated for cervical intraepithelial neoplasia (CIN) III by conization. Investigations included serological and bacteriological screening, histopathology and colposcopy. A history of STD was reported by 20 men (33%), and 34 (57%) had signs of STD including genital HPV infection, 2 (3%) had a chlamydial infection, one had molluscum contageosum, 7 (12%) had genital warts and 24 (40%) had abnormal acetowhite epithelium, indicating HPV infection. The HPV lesions were principally subclinical and located on the glans penis and the prepuce. Colposcopy and application of acetic acid are essential for detection. The gynaecologist and venereologist must recognize the sexually transmitted nature of CIN, and the causal link between CIN and HPV infection. Assessment and treatment of the male sexual partner of women treated for CIN might be an essential part in disease control with the aim of preventing cervical cancer.

Entities:  

Mesh:

Year:  1988        PMID: 2839224     DOI: 10.1111/j.1471-0528.1988.tb09493.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  2 in total

1.  Human papillomavirus genomes in male urethral cells.

Authors:  G Della Torre; R Donghi; P O de Campos Lima; G Pasquini; S Pilotti; R Koronel; M A Pierotti; G De Palo; G Della Porta; F Rilke
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

2.  Genital human papillomavirus lesions of the male sexual partners: the diagnostic accuracy of peniscopy.

Authors:  M Hippeläinen; M Yliskoski; S Saarikoski; S Syrjänen; K Syrjänen
Journal:  Genitourin Med       Date:  1991-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.